Idiopathic Mast Cell Activation Disorder

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-21
Clinical Trial Update: Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) [Phase 2]
Phase 2 study of FSD201 for chronic pain associated with idiopathic mast cell activation syndrome (MCAS/MCAD) was terminated; results have b…